Helen McShane

Helen McShane is a Professor of Vaccinology at the University of Oxford's Medical Sciences Division and Director of the Oxford NIHR Biomedical Research Centre. Her research focuses on tuberculosis (TB) vaccine development, particularly addressing the limitations of the BCG vaccine through novel prime-boost strategies and aerosol delivery methods.

• Key research areas include immune correlates of protection against TB, vaccine efficacy in HIV-infected populations, and translational immunology
• She leads clinical trials across the UK, The Gambia, South Africa, Senegal, and Uganda

Recent work explores mucosal immune responses and experimental infection models for vaccine testing. Her scientific accolades include Fellowships from the Royal College of Physicians and the Academy of Medical Sciences.